富血小板血浆用于治疗椎间盘源性腰痛方面的研究进展
Research Progress of Platelet-Rich Plasma in the Treatment of Discogenic Low Back Pain
DOI: 10.12677/acm.2025.1541020, PDF,   
作者: 盘啸涵*, 郝 杰#：重庆医科大学附属第一医院，骨科，重庆；重庆市卫生健康委员会运动系统再生与转化医学重点实验室/骨科实验室，重庆；江 维：重庆市南川区人民医院，骨科，重庆
关键词: 富血小板血浆；椎间盘源性腰痛；腰椎间盘退变；动物实验；人体实验；Plate-Rich Plasma； Discogenic Low Back Pain； Lumbar Disc Degeneration； Animal Studies； Human Studies
摘要: 本综述整理了富血小板血浆(Platelet-Rich Plasma, PRP)在椎间盘源性腰痛(Discogenic Low Back Pain, DLBP)治疗中的研究进展。通过查阅近年来相关文献，分析了PRP的作用机制、制备及活化方式，并探讨了其在动物实验和人体实验中的效果。PRP通过血小板分泌的生物活性因子对DLBP具有潜在治疗作用，可通过传统或商用方法制备并活化。动物实验显示，PRP对椎间盘退变(Intervertebral Disc Degeneration, IDD)具有显著疗效，改善MRI信号；人体实验则表明PRP可改善疼痛和功能评分，尽管部分研究结果存在差异。现有研究表明PRP安全性较高，但关于其分类、制备及活化方法存在异质性。影像学评估PRP疗效的研究较少，未来需开展更大规模的临床试验，纳入更多客观指标评估其疗效，并通过系统性综述和学术会议制定相关指南，指导PRP的临床应用。
Abstract: This review provides an overview of the research progress on Platelet-Rich Plasma (PRP) in the treatment of Discogenic Low Back Pain (DLBP). By examining recent literature, we explore the mechanisms of action, preparation, and activation of PRP, as well as its effects in both animal and human studies. PRP shows potential therapeutic benefits for DLBP through bioactive factors secreted by platelets, and it can be prepared and activated using either traditional or commercial methods. Animal studies have demonstrated significant improvements in Intervertebral Disc Degeneration (IDD), including enhanced MRI signals. In human studies, PRP has been shown to improve pain and functional scores, though some studies report varying results. While existing research confirms the safety of PRP, there is considerable variation in its classification, preparation, and activation methods. Additionally, there is a lack of studies utilizing imaging to assess PRP’s efficacy. Future clinical trials should be larger in scale, incorporating more objective measures, and systematic reviews and academic conferences are needed to establish guidelines for the clinical use of PRP.
文章引用：盘啸涵, 江维, 郝杰. 富血小板血浆用于治疗椎间盘源性腰痛方面的研究进展[J]. 临床医学进展, 2025, 15(4): 974-983. https://doi.org/10.12677/acm.2025.1541020

参考文献

[1] Knezevic, N.N., Candido, K.D., Vlaeyen, J.W.S., Van Zundert, J. and Cohen, S.P. (2021) Low Back Pain. The Lancet, 398, 78-92. [Google Scholar] [CrossRef] [PubMed]
[2] (2018) Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1789-1858.
[3] Teraguchi, M., Yoshimura, N., Hashizume, H., Muraki, S., Yamada, H., Minamide, A., et al. (2014) Prevalence and Distribution of Intervertebral Disc Degeneration over the Entire Spine in a Population-Based Cohort: The Wakayama Spine Study. Osteoarthritis and Cartilage, 22, 104-110. [Google Scholar] [CrossRef] [PubMed]
[4] Peng, Y. and Lv, F. (2015) Symptomatic versus Asymptomatic Intervertebral Disc Degeneration: Is Inflammation the Key? Critical Reviews in Eukaryotic Gene Expression, 25, 13-21. [Google Scholar] [CrossRef] [PubMed]
[5] Weinstein, J.N., Tosteson, T.D., Lurie, J.D., Tosteson, A.N.A., Hanscom, B., Skinner, J.S., et al. (2006) Surgical vs Nonoperative Treatment for Lumbar Disk Herniation: The Spine Patient Outcomes Research Trial (SPORT): A Randomized Trial. JAMA, 296, 2441-2250. [Google Scholar] [CrossRef] [PubMed]
[6] Yurube, T., Ito, M., Kakiuchi, Y., Kuroda, R. and Kakutani, K. (2020) Autophagy and mTOR Signaling during Intervertebral Disc Aging and Degeneration. JOR Spine, 3, e1082. [Google Scholar] [CrossRef] [PubMed]
[7] Singh, G.K., Talawar, P., Kumar, A., Sharma, R.S., Purohit, G. and Bhandari, B. (2023) Effect of Autologous Platelet-Rich Plasma (PRP) on Low Back Pain in Patients with Prolapsed Intervertebral Disc: A Randomised Controlled Trial. Indian Journal of Anaesthesia, 67, 277-282. [Google Scholar] [CrossRef] [PubMed]
[8] Navani, A. (2024) The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-Up. Pain Physician Journal, 27, E65-E77. [Google Scholar] [CrossRef] 
[9] Brass, L. (2010) Understanding and Evaluating Platelet Function. Hematology, 2010, 387-396. [Google Scholar] [CrossRef] [PubMed]
[10] Cohn, C.S., Lockhart, E. and McCullough, J.J. (2015) The Use of Autologous Platelet‐Rich Plasma in the Orthopedic Setting. Transfusion, 55, 1812-1820. [Google Scholar] [CrossRef] [PubMed]
[11] Jha, A.K., Udayan, U.K., Roy, P.K., Amar, A.K.J. and Chaudhary, R.K.P. (2017) Original Article: Platelet‐Rich Plasma with Microneedling in Androgenetic Alopecia along with Dermoscopic Pre‐ and Post‐Treatment Evaluation. Journal of Cosmetic Dermatology, 17, 313-318. [Google Scholar] [CrossRef] [PubMed]
[12] Dale, D.C., Boxer, L. and Liles, W.C. (2008) The Phagocytes: Neutrophils and Monocytes. Blood, 112, 935-945. [Google Scholar] [CrossRef] [PubMed]
[13] van Gils, J.M., Zwaginga, J.J. and Hordijk, P.L. (2008) Molecular and Functional Interactions among Monocytes, Platelets, and Endothelial Cells and Their Relevance for Cardiovascular Diseases. Journal of Leukocyte Biology, 85, 195-204. [Google Scholar] [CrossRef] [PubMed]
[14] Everts, P.A.M., Knape, J.T.A., Weibrich, G., Schönberger, J.P.A.M., Hoffmann, J., Overdevest, E.P., et al. (2006) Platelet-rich Plasma and Platelet Gel: A Review. The Journal of ExtraCorporeal Technology, 38, 174-187. [Google Scholar] [CrossRef] 
[15] Scully, D., Naseem, K.M. and Matsakas, A. (2018) Platelet Biology in Regenerative Medicine of Skeletal Muscle. Acta Physiologica, 223, e13071. [Google Scholar] [CrossRef] [PubMed]
[16] Baig, M.Z., Abdullah, U.E.H., Muhammad, A., Aziz, A., Syed, M.J. and Darbar, A. (2021) Use of Platelet-Rich Plasma in Treating Low Back Pain: A Review of the Current Literature. Asian Spine Journal, 15, 117-126. [Google Scholar] [CrossRef] [PubMed]
[17] Peng, B., Geue, S., Coman, C., Münzer, P., Kopczynski, D., Has, C., et al. (2018) Identification of Key Lipids Critical for Platelet Activation by Comprehensive Analysis of the Platelet Lipidome. Blood, 132, e1-e12. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, Y., Wang, S., Liu, X. and Kang, Z. (2023) Platelet-Rich Plasma Promotes Peripheral Nerve Regeneration after Sciatic Nerve Injury. Neural Regeneration Research, 18, 375-381. [Google Scholar] [CrossRef] [PubMed]
[19] Chahla, J., Cinque, M.E., Piuzzi, N.S., Mannava, S., Geeslin, A.G., Murray, I.R., et al. (2017) A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature. Journal of Bone and Joint Surgery, 99, 1769-1779. [Google Scholar] [CrossRef] [PubMed]
[20] Fang, J., Wang, X., Jiang, W., Zhu, Y., Hu, Y., Zhao, Y., et al. (2020) Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries. Tissue Engineering Part B: Reviews, 26, 571-585. [Google Scholar] [CrossRef] [PubMed]
[21] Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E. and Georgeff, K.R. (1998) Platelet-Rich Plasma. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 85, 638-646. [Google Scholar] [CrossRef] [PubMed]
[22] Landesberg, R., Roy, M. and Glickman, R.S. (2000) Quantification of Growth Factor Levels Using a Simplified Method of Platelet-Rich Plasma Gel Preparation. Journal of Oral and Maxillofacial Surgery, 58, 297-300. [Google Scholar] [CrossRef] [PubMed]
[23] Okuda, K., Kawase, T., Momose, M., Murata, M., Saito, Y., Suzuki, H., et al. (2003) Platelet‐Rich Plasma Contains High Levels of Platelet‐Derived Growth Factor and Transforming Growth Factor‐β and Modulates the Proliferation of Periodontally Related Cells in Vitro. Journal of Periodontology, 74, 849-857. [Google Scholar] [CrossRef] [PubMed]
[24] Sabarish, R. (2015) A Comparison of Platelet Count and Enrichment Percentages in the Platelet Rich Plasma (PRP) Obtained Following Preparation by Three Different Methods. Journal of Clinical and Diagnostic Research, 9, ZC10-ZC12. [Google Scholar] [CrossRef] [PubMed]
[25] Oudelaar, B.W., Peerbooms, J.C., Huis in ‘t Veld, R. and Vochteloo, A.J.H. (2018) Concentrations of Blood Components in Commercial Platelet-Rich Plasma Separation Systems: A Review of the Literature. The American Journal of Sports Medicine, 47, 479-487. [Google Scholar] [CrossRef] [PubMed]
[26] Chen, X., Jones, I.A., Park, C. and Vangsness, C.T. (2017) The Efficacy of Platelet-Rich Plasma on Tendon and Ligament Healing: A Systematic Review and Meta-Analysis with Bias Assessment. The American Journal of Sports Medicine, 46, 2020-2032. [Google Scholar] [CrossRef] [PubMed]
[27] Ünlü, A., Yilmaz, S., Eker, İ., Çetinkaya, R.A., Pekel, A., Sağkan, R.I., et al. (2020) A Cycle of Freezing and Thawing as a Modified Method for Activating Platelets in Platelet-Rich Plasma to Use in Regenerative Medicine. Panamerican Journal of Trauma, Critical Care & Emergency Surgery, 9, 101-104. [Google Scholar] [CrossRef] 
[28] Sadeghi-Ataabadi, M., Mostafavi-pour, Z., Vojdani, Z., Sani, M., Latifi, M. and Talaei-Khozani, T. (2017) Fabrication and Characterization of Platelet-Rich Plasma Scaffolds for Tissue Engineering Applications. Materials Science and Engineering: C, 71, 372-380. [Google Scholar] [CrossRef] [PubMed]
[29] Du, L., Miao, Y., Li, X., Shi, P. and Hu, Z. (2018) A Novel and Convenient Method for the Preparation and Activation of PRP without Any Additives: Temperature Controlled PRP. BioMed Research International, 2018, Article ID: 1761865. [Google Scholar] [CrossRef] [PubMed]
[30] Irmak, G., Demirtaş, T.T. and Gümüşderelioğlu, M. (2020) Sustained Release of Growth Factors from Photoactivated Platelet Rich Plasma (PRP). European Journal of Pharmaceutics and Biopharmaceutics, 148, 67-76. [Google Scholar] [CrossRef] [PubMed]
[31] Dohan Ehrenfest, D.M., Rasmusson, L. and Albrektsson, T. (2009) Classification of Platelet Concentrates: From Pure Platelet-Rich Plasma (P-PRP) to Leucocyte-and Platelet-Rich Fibrin (l-PRF). Trends in Biotechnology, 27, 158-167. [Google Scholar] [CrossRef] [PubMed]
[32] DeLong, J.M., Russell, R.P. and Mazzocca, A.D. (2012) Platelet-Rich Plasma: The PAW Classification System. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 28, 998-1009. [Google Scholar] [CrossRef] [PubMed]
[33] Mishra, A., Harmon, K., Woodall, J. and Vieira, A. (2012) Sports Medicine Applications of Platelet Rich Plasma. Current Pharmaceutical Biotechnology, 13, 1185-1195. [Google Scholar] [CrossRef] [PubMed]
[34] Mautner, K., Malanga, G.A., Smith, J., Shiple, B., Ibrahim, V., Sampson, S., et al. (2015) A Call for a Standard Classification System for Future Biologic Research: The Rationale for New PRP Nomenclature. PM&R, 7, S53-S59. [Google Scholar] [CrossRef] [PubMed]
[35] Magalon, J., Chateau, A.L., Bertrand, B., Louis, M.L., Silvestre, A., Giraudo, L., et al. (2016) DEPA Classification: A Proposal for Standardising PRP Use and a Retrospective Application of Available Devices. BMJ Open Sport & Exercise Medicine, 2, e000060. [Google Scholar] [CrossRef] [PubMed]
[36] Lana, J.F.S.D., Purita, J., Paulus, C., Huber, S.C., Rodrigues, B.L., Rodrigues, A.A., et al. (2017) Contributions for Classification of Platelet Rich Plasma—Proposal of a New Classification: Marspill. Regenerative Medicine, 12, 565-574. [Google Scholar] [CrossRef] [PubMed]
[37] Wang, S., Jin, J., Guo, Y., Ma, L., Chang, Q., Peng, X., et al. (2016) Intervertebral Disc Regeneration Using Platelet-Rich Plasma-Containing Bone Marrow-Derived Mesenchymal Stem Cells: A Preliminary Investigation. Molecular Medicine Reports, 13, 3475-3481. [Google Scholar] [CrossRef] [PubMed]
[38] Hou, Y., Shi, G., Shi, J., Xu, G., Guo, Y. and Xu, P. (2015) Study Design: In Vitro and in Vivo Assessment of Bone Morphogenic Protein 2 Combined with Platelet-Rich Plasma on Treatment of Disc Degeneration. International Orthopaedics, 40, 1143-1155. [Google Scholar] [CrossRef] [PubMed]
[39] Ma, C., Wang, R., Zhao, D., Wang, N., Han, Y., Wang, S., et al. (2019) Efficacy of Platelet-Rich Plasma Containing Xenogenic Adipose Tissue-Derived Stromal Cells on Restoring Intervertebral Disc Degeneration: A Preclinical Study in a Rabbit Model. Pain Research and Management, 2019, Article ID: 6372356. [Google Scholar] [CrossRef] [PubMed]
[40] Chai, Q., Zhang, B., Da, Y., Wang, W., Gao, Y., Yao, M., et al. (2023) Enhancement and Repair of Degenerative Intervertebral Disc in Rats Using Platelet-Rich Plasma/Ferulic Acid Hydrogel. Cartilage, 14, 506-515. [Google Scholar] [CrossRef] [PubMed]
[41] Hasegawa, T., Akeda, K., Yamada, J., Kawaguchi, K., Takegami, N., Fujiwara, T., et al. (2023) Regenerative Effects of Platelet-Rich Plasma Releasate Injection in Rabbit Discs Degenerated by Intradiscal Injection of Condoliase. Arthritis Research & Therapy, 25, Article No. 216. [Google Scholar] [CrossRef] [PubMed]
[42] Wang, F., Guo, K., Nan, L., Wang, S., Lu, J., Wang, Q., et al. (2023) Kartogenin-Loaded Hydrogel Promotes Intervertebral Disc Repair via Protecting MSCs against Reactive Oxygen Species Microenvironment by Nrf2/TXNIP/NLRP3 Axis. Free Radical Biology and Medicine, 204, 128-150. [Google Scholar] [CrossRef] [PubMed]
[43] Peng, B., Xu, B., Wu, W., Du, L., Zhang, T. and Zhang, J. (2023) Efficacy of Intradiscal Injection of Platelet-Rich Plasma in the Treatment of Discogenic Low Back Pain: A Single-Arm Meta-Analysis. Medicine, 102, e33112. [Google Scholar] [CrossRef] [PubMed]
[44] Everts, P., Onishi, K., Jayaram, P., Lana, J.F. and Mautner, K. (2020) Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. International Journal of Molecular Sciences, 21, Article 7794. [Google Scholar] [CrossRef] [PubMed]
[45] Tuakli‐Wosornu, Y.A., Terry, A., Boachie‐Adjei, K., Harrison, J.R., Gribbin, C.K., LaSalle, E.E., et al. (2015) Lumbar Intradiskal Platelet‐Rich Plasma (PRP) Injections: A Prospective, Double‐Blind, Randomized Controlled Study. PM&R, 8, 1-10. [Google Scholar] [CrossRef] [PubMed]
[46] Lutz, C., Cheng, J., Prysak, M., Zukofsky, T., Rothman, R. and Lutz, G. (2022) Clinical Outcomes Following Intradiscal Injections of Higher-Concentration Platelet-Rich Plasma in Patients with Chronic Lumbar Discogenic Pain. International Orthopaedics, 46, 1381-1385. [Google Scholar] [CrossRef] [PubMed]
[47] Le, V., Nguyen Dao, L.T. and Nguyen, A.M. (2023) Transforaminal Injection of Autologous Platelet-Rich Plasma for Lumbar Disc Herniation: A Single-Center Prospective Study in Vietnam. Asian Journal of Surgery, 46, 438-443. [Google Scholar] [CrossRef] [PubMed]
[48] Kawabata, S., Nagai, S., Ito, K., Takeda, H., Ikeda, D., Kawano, Y., et al. (2024) Intradiscal Administration of Autologous Platelet‐Rich Plasma in Patients with Modic Type 1 Associated Low Back Pain: A Prospective Pilot Study. JOR Spine, 7, e1320. [Google Scholar] [CrossRef] [PubMed]
[49] Zielinski, M.A., Evans, N.E., Bae, H., et al. (2022) Safety and Efficacy of Platelet Rich Plasma for Treatment of Lumbar Discogenic Pain: A Prospective, Multicenter, Randomized, Double-Blind Study. Pain Physician, 25, 29-34.
[50] Akeda, K., Ohishi, K., Masuda, K., Bae, W.C., Takegami, N., Yamada, J., et al. (2017) Intradiscal Injection of Autologous Platelet-Rich Plasma Releasate to Treat Discogenic Low Back Pain: A Preliminary Clinical Trial. Asian Spine Journal, 11, 380-389. [Google Scholar] [CrossRef] [PubMed]
[51] Lutz, G.E. (2017) Increased Nuclear T2 Signal Intensity and Improved Function and Pain in a Patient One Year after an Intradiscal Platelet–rich Plasma Injection. Pain Medicine, 18, 1197-1199. [Google Scholar] [CrossRef] [PubMed]
[52] Yang, H., Yuan, C., Wu, C., Qian, J., Shi, Q., Li, X., et al. (2016) The Role of TGF‐β1/Smad2/3 Pathway in Platelet‐rich Plasma in Retarding Intervertebral Disc Degeneration. Journal of Cellular and Molecular Medicine, 20, 1542-1549. [Google Scholar] [CrossRef] [PubMed]
[53] Gelalis, I.D., Christoforou, G., Charchanti, A., Gkiatas, I., Pakos, E., Papadopoulos, D., et al. (2018) Autologous Platelet-Rich Plasma (PRP) Effect on Intervertebral Disc Restoration: An Experimental Rabbit Model. European Journal of Orthopaedic Surgery & Traumatology, 29, 545-551. [Google Scholar] [CrossRef] [PubMed]
[54] Levi, D., Horn, S., Tyszko, S., Levin, J., Hecht-Leavitt, C. and Walko, E. (2015) Intradiscal Platelet-Rich Plasma Injection for Chronic Discogenic Low Back Pain: Preliminary Results from a Prospective Trial. Pain Medicine, 17, 1010-1022. [Google Scholar] [CrossRef] [PubMed]
[55] Cheng, J., Santiago, K.A., Nguyen, J.T., Solomon, J.L. and Lutz, G.E. (2019) Treatment of Symptomatic Degenerative Intervertebral Discs with Autologous Platelet-Rich Plasma: Follow-Up at 5-9 Years. Regenerative Medicine, 14, 831-840. [Google Scholar] [CrossRef] [PubMed]
[56] Jain, D., Goyal, T., Verma, N., Paswan, A.K. and Dubey, R.K. (2020) Intradiscal Platelet-Rich Plasma Injection for Discogenic Low Back Pain and Correlation with Platelet Concentration: A Prospective Clinical Trial. Pain Medicine, 21, 2719-2725. [Google Scholar] [CrossRef] [PubMed]
[57] Zhang, J., Liu, D., Gong, Q., Chen, J. and Wan, L. (2022) Intradiscal Autologous Platelet‐Rich Plasma Injection for Discogenic Low Back Pain: A Clinical Trial. BioMed Research International, 2022, Article ID: 9563693. [Google Scholar] [CrossRef] [PubMed]
[58] Akeda, K., Ohishi, K., Takegami, N., Sudo, T., Yamada, J., Fujiwara, T., et al. (2022) Platelet-Rich Plasma Releasate versus Corticosteroid for the Treatment of Discogenic Low Back Pain: A Double-Blind Randomized Controlled Trial. Journal of Clinical Medicine, 11, Article 304. [Google Scholar] [CrossRef] [PubMed]

为你推荐